F. Tran Mau-Them,L. Guibaud,L. Duplomb,B. Keren,K. Lindstrom,I. Marey,F. Mochel,M. J. van den Boogaard,R. Oegema,C. Nava,A. Masurel,T. Jouan,F. E. Jansen,M. Au,Agnes H. Chen,M. Cho,Y. Duffourd,E. Lozier,F. Konovalov,A. Sharkov,S. Korostelev,B. Urteaga,P. Dickson,M. Vera,Julián A. Martínez-Agosto,A. Begemann,M. Zweier,T. Schmitt-Mechelke,A. Rauch,C. Philippe,K. van Gassen,S. Nelson,J. M. Graham,J. Friedman,L. Faivre,H. J. Lin,C. Thauvin-Robinet,A. Vitobello,M.J. van den Boogaard,F.E. Jansen,J.M. Graham,H.J. Lin

Abstract:PurposeDevelopmental and epileptic encephalopathies (DEEs) are severe clinical conditions characterized by stagnation or decline of cognitive and behavioral abilities preceded, accompanied or followed by seizures. Because DEEs are clinically and genetically heterogeneous, next-generation sequencing, especially exome sequencing (ES), is becoming a first-tier strategy to identify the molecular etiologies of these disorders.MethodsWe combined ES analysis and international data sharing.ResultsWe identified 11 unrelated individuals with DEE and de novo heterozygous truncating variants in the interferon regulatory factor 2–binding protein-like gene (IRF2BPL). The 11 individuals allowed for delineation of a consistent neurodevelopmental disorder characterized by mostly normal initial psychomotor development followed by severe global neurological regression and epilepsy with nonspecific electroencephalogram (EEG) abnormalities and variable central nervous system (CNS) anomalies. IRF2BPL, also known as enhanced at puberty protein 1 (EAP1), encodes a transcriptional regulator containing a C-terminal RING-finger domain common to E3 ubiquitin ligases. This domain is required for its repressive and transactivating transcriptional properties. The variants identified are expected to encode a protein lacking the C-terminal RING-finger domain.ConclusionsThese data support the causative role of truncating IRF2BPL variants in pediatric neurodegeneration and expand the spectrum of transcriptional regulators identified as molecular factors implicated in genetic developmental and epileptic encephalopathies.

De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy